RPL6P29

Across TCGA pan-cancer cohorts, RPL6P29 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL6P29’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where RPL6P29 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL6P29 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD, THCA, and CHOL are the cancer types where RPL6P29 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL6P29 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Male	All	−0.110	.008	4	view →
THCA	Female	II,III,IV	+0.046	.009	2	view →
CHOL	All	All	+0.047	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL6P29–PAAD

Open the PAAD breakdown →